AMTB

Amerant Bancorp Inc

Add to Watchlist

Advanced Chart

19.020

+0.16(0.848%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

19.020

Open

19.020

VWAP

19.02

Vol

631.00

Mkt Cap

787.39M

Low

19.020

Amount

12.00K

EV/EBITDA(TTM)

97.35

Total Shares

33.72M

1.60B

EV/OCF(TTM)

1.31

P/S(TTM)

2.55

Amerant Bancorp Inc. is a bank holding company. The Company operates through its subsidiary, Amerant Bank, N.A. (the Bank). It provides individuals and businesses with a comprehensive array of deposit, credit, investment, wealth management, retail banking, mortgage services and fiduciary services. It offers a variety of trust and estate planning products and services catering to high-net-worth customers. Its trust and estate planning products include simple and complex trusts, private foundations and personal investment companies. It offers a full suite of online banking services, including online account opening for domestic and international customers, access to account balances, statements and other documents, Zelle for consumers and businesses, online transfers, online bill payment and electronic delivery of customer statements, as well as automated teller machines, and banking by mobile devices, telephone and mail.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

109.99M

+7.24%

0.518

+115.83%

110.98M

+5.24%

0.590

+18%

108.06M

+6.15%

0.535

+98.15%

Estimates Revision

The market is revising Upward the revenue expectations for Amerant Bancorp Inc. (AMTB) for FY2025, with the revenue forecasts being adjusted by 0.14% over the past three months. During the same period, the stock price has changed by 5.96%.

Revenue Estimates for FY2025

Revise Upward

+0.14%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.35%

In Past 3 Month

Stock Price

Go Up

+5.96%

In Past 3 Month

3 Analyst Rating

26.18% Upside

Wall Street analysts forecast AMTB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMTB is 24.00 USD with a low forecast of 22.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

26.18% Upside

Current: 19.020

Low

22.00

Averages

24.00

High

26.00

26.18% Upside

Current: 19.020

Low

22.00

Averages

24.00

High

26.00

Keefe Bruyette

Market Perform

maintain

$20 -> $22

2025-07-28

Reason

Keefe Bruyette

Price Target

$20 -> $22

2025-07-28

maintain

Market Perform

Reason

Keefe Bruyette raised the firm's price target on Amerant Bancorp to $22 from $20 and keeps a Market Perform rating on the shares.

Piper Sandler

Stephen Scouten

Overweight

maintain

$25 -> $26

2025-07-28

Reason

Piper Sandler

Stephen Scouten

Price Target

$25 -> $26

2025-07-28

maintain

Overweight

Reason

Piper Sandler analyst Stephen Scouten raised the firm's price target on Amerant Bancorp to $26 from $25 and keeps an Overweight rating on the shares following quarterly results. The firm notes the company remains focused on delivering a 1% ROA in the second half of 2025, and was pleased to see a slowdown in growth, branch expansions and overall near-term aggressiveness as it works to clean-up the bank. Piper thinks this is a simple story, frankly, and all Amerant needs to do is clean-up credit and grow deposits, so hopefully this newfound patience persists.

Keefe Bruyette

Market Perform

downgrade

$24 -> $20

2025-04-25

Reason

Keefe Bruyette

Price Target

$24 -> $20

2025-04-25

downgrade

Market Perform

Reason

Keefe Bruyette lowered the firm's price target on Amerant Bancorp to $20 from $24 and keeps a Market Perform rating on the shares.

Raymond James

Michael Rose

Outperform -> Market Perform

downgrade

2025-04-24

Reason

Raymond James

Michael Rose

Price Target

2025-04-24

downgrade

Outperform -> Market Perform

Reason

Raymond James analyst Michael Rose downgraded Amerant Bancorp to Market Perform from Outperform without a price target. The company's Q1 results fell short of forecasts on a core earnings basis as credit headwinds are persisting, the analyst tells investors in a research note. The firm is stepping to the sideline given the quarter's "negative migration." Coupled with an uncertain backdrop in light of tariffs and other policy changes out of the Trump administration and a reduction in its loan growth outlook, "a wait and see approach is now warranted" for Amerant, contends Raymond James.

Stephens & Co.

Russell Gunther

Buy

Reiterates

$29

2025-01-23

Reason

Stephens & Co.

Russell Gunther

Price Target

$29

2025-01-23

Reiterates

Buy

Reason

Stephens & Co.

Russell Gunther

Buy

Reiterates

$29

2025-01-03

Reason

Stephens & Co.

Russell Gunther

Price Target

$29

2025-01-03

Reiterates

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Amerant Bancorp Inc (AMTB.N) is 8.95, compared to its 5-year average forward P/E of 14.00. For a more detailed relative valuation and DCF analysis to assess Amerant Bancorp Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

14.00

Current PE

8.95

Overvalued PE

20.39

Undervalued PE

7.61

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.38

Current PS

1.75

Overvalued PS

3.07

Undervalued PS

1.70